ArticleAnemia2026
Serum Metabolomic Signatures of Iron Deficiency Anemia: An Untargeted LC-HRMS-Based Case-Control Study.
Article in Anemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Iron deficiency anemia is primarily evaluated using hematological and iron-related parameters; however, these markers may not fully reflect the systemic metabolic consequences of impaired oxygen delivery and altered iron availability. This study aimed to characterize serum metabolomic alterations associated with iron deficiency anemia using an untargeted LC-HRMS approach. Materials and Methods: Serum samples from 47 individuals with iron deficiency anemia and 50 healthy controls were analyzed by LC-HRMS in positive and negative ionization modes. Data processing and metabolite annotation were performed using MassCube and MZmine workflows. Multivariate and univariate analyses, covariate-adjusted models, metabolite set enrichment analysis, correlations with hematologic/iron indices, and internally cross-validated exploratory ROC analyses were performed. Results: PCA showed partial separation between iron deficiency anemia and control groups, while OPLS-DA demonstrated clearer group discrimination. Differential metabolites indicated prominent alterations in amino acid, central carbon, nitrogen-related, and redox-associated pathways. The principal amino-acid/nitrogen-related differences remained significant after adjustment for age, sex, albumin, and total protein. In the full cohort, several discriminatory metabolites correlated with hemoglobin, ferritin, and transferrin saturation, although these correlations did not remain FDR-significant within the IDA group alone. Repeated stratified 5-fold cross-validation yielded a mean AUC of 0.964 for the three-metabolite model comprising isoleucine, isonicotinic acid, and phenylalanine. Conclusion: Untargeted serum metabolomics revealed a distinct metabolic signature in iron deficiency anemia, mainly involving amino acid remodeling, central carbon metabolism, nitrogen balance, and redox-associated pathways. These findings provide a basis for future targeted and externally validated metabolomics studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.